Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsJACC, 2018
- Rationale and design of REDUCE‐IT: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention TrialClinical Cardiology, 2017
- Investigator-Reported Bleeding Versus Post Hoc Adjudication of BleedingJACC, 2016
- Architecture design of a generic centralized adjudication module integrated in a web-based clinical trial management systemClinical Trials, 2015
- 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical TrialsJACC, 2015
- Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) TrialJACC, 2014
- ACCF/AHA 2011 Key Data Elements and Definitions of a Base Cardiovascular Vocabulary for Electronic Health RecordsJACC, 2011
- Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])American Heart Journal, 2010
- Do we need to adjudicate major clinical events?Clinical Trials, 2008
- Misreporting of myocardial infarction end points: Results of adjudication by a central clinical events committee in the PARAGON-B trialAmerican Heart Journal, 2002